Inhibition of MMP-9 by green tea catechins and prediction of their interaction by molecular docking analysis

Biomedicine and Pharmacotherapy

Volumn 84, Issue , 2016, Pages 340-347

  Sarkar, Jaganmay ^a   Nandy, Suman Kumar ^a   Chowdhury, Animesh ^a,b   Chakraborti, Tapati ^a   Chakraborti, Sajal ^a  

^a UNIVERSITY OF KALYANI   (India)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Green tea catechins; MMP 9; Molecular docking; PASMC; ProMMP 9

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GELATINASE B; GREEN TEA EXTRACT; UNCLASSIFIED DRUG; LIGAND; MATRIX METALLOPROTEINASE INHIBITOR; POLYPHENOL; TEA;

ANIMAL CELL; ARTICLE; CELL CULTURE; COMPUTER MODEL; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; TEA; ANIMAL; BINDING SITE; BOVINE; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; BINDING SITES; CATECHIN; CATTLE; CELLS, CULTURED; HUMANS; LIGANDS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MOLECULAR DOCKING SIMULATION; POLYPHENOLS; TEA;

EID: 84988660350     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.09.049     Document Type: Article

References (30)

1. [1] Yang, C.S., Hong, J., Hou, Z., Sang, S., Green tea polyphenols: antioxidative and prooxidative effects. J. Nutr., 134, 2004, 3181S.
2. [2] Sasazuki, S., Kodama, H., Yoshimasu, K., Liu, Y., Washio, M., Tanaka, K., Tokunaga, S., Kono, S., Arai, H., Doi, Y., Kawano, T., Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann. Epidemiol. 10 (2000), 401–4408.
3. [3] Chowdhury, A., Sarkar, J., Chakraborti, T., Pramanik, P.K., Chakraborti, S., Protective role of epigallocatechin-3-gallate in health and disease: a perspective. Biomed. Pharmacother. 78 (2016), 50–59.
4. [4] Suzuki, J.I., Ogawa, M., Izawa, A., Sagesaka, Y.M., Isobe, M., Dietary consumption of green tea catechins attenuate hyperlipidaemia-induced atherosclerosis and systemic organ damage in mice. Acta Cardiologica. 60 (2005), 271–276.
5. [5] Tijburg, L.B., Wiseman, S.A., Meijer, G.W., Weststrate, J.A., Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135 (1997), 37–47.
6. [6] Bryans, J.A., Judd, P.A., Ellis, P.A., The effect of consuming instant black tea on postprandial plasma glucose and insulin concentrations in healthy humans. J. Am. Coll. Nutr. 26 (2007), 471–477.
7. [7] Waltner-Law, M.E., Wang, X.L., Law, B.K., Hall, R.K., Nawano, M., Granner, D.K., Epigallocatechin gallate a constituent of green tea, represses hepatic glucose production. J. Biol. Chem. 277 (2002), 34933–34940.
8. [8] Yang, C.S., Wang, Z.Y., Tea and cancer. J. Natl. Cancer. Inst. 85 (1993), 1038–1049.
9. [9] Dufresne, C.J., Farnworth, E.R., A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem. 12 (2001), 404–421.
10. [10] Woessner, J.F. Jr., Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb J. 5 (1991), 2145–2154.
11. [11] Sperti, G., van Leeuwen, R.T., Quax, P.H., Maseri, A., Kluft, C., Cultured rat aortic vascular smooth muscle cells digest naturally produced extracellular matrix. Involvement of plasminogen-dependent and plasminogen-independent pathways. Circ. Res. 71 (1992), 385–392.
12. [12] Jenkins, G.M., Crow, M.T., Bilato, C., Gluzband, Y., Ryu, W.S., Li, Z., Stetler-Stevenson, W., Nater, C., Froehlich, J.P., Lakatta, E.G., Cheng, L., Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries. Circulation 97 (1998), 82–90.
13. [13] Godin, D., Ivan, E., Johnson, C., Magid, R., Galis, Z.S., Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102 (2000), 2861–2866.
14. [14] Feldman, L.J., Mazighi, M., Scheuble, A., Deux, J.F., Benedetti, E.D., Badier-Commander, C., Brambilla, E., Henin, D., Steg, P.G., Jacob, M.P., Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 103 (2001), 3117–3122.
15. [15] Moscatelli, D., Rifkin, D.B., Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 948 (1988), 67–85.
16. [16] Qiao, X., Zhai, X., Wang, J., Zhao, X., Yang, X., Lv, J., Ma, L., Zhang, L., Wang, Y., Zhang, S., W. Yue, Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer. Onco. Targets Ther. 9 (2016), 299–305.
17. [17] Frisdal, E., Gest, V., Vieillard-Baron, A., Levame, M., Lepetit, H., Eddahibi, S., Lafuma, C., Harf, A., Adnot, S., Dortho, M.P., Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur. Respir. J. 18 (2001), 838–845.
18. [18] Archer, S., Rich, S., Primary pulmonary hypertension: a vascular biology and translational research work in progress. Circulation 102 (2000), 2781–2791.
19. [19] George, J., D'Armiento, J., Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice. J. Hypertens. 29 (2011), 299–308.
20. [20] Demeule, M., Brossard, M., Page, M., Gingras, D., Beliveau, R., Matrix metalloproteinases inhibition by green tea catechins. Biochim. Biophys. Acta 1478 (2000), 51–60.
21. [21] You, R., Zheng, M., McKeown-Longo, P.J., The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J. Biol. Chem. 285 (2010), 36255–36259.
22. [22] Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., Klenk, D.C., Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985), 76–85.
23. [23] Altschul, S.F., Madden, T.L., Schäffer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997), 3389–3402.
24. [24] Webb, B., Sali, A., Comparative protein structure modeling using Modeller. Curr. Protoc. Bioinform. 8 (2014), 5–6.
25. [25] Feng, Z., Chen, L., Maddula, H., Akcan, O., Oughtred, R., Berman, H.M., Westbrook, J., Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics 20 (2004), 2153–2155.
26. [26] Kim, S., Thiessen, P.A., Bolton, E.E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B.A., Wang, J., PubChem substance and compound databases. Nucleic Acids Res. 44D1 (2016), D1202–D1213.
27. [27] Jones, G., Willett, P., Glen, R.C., Leach, A.R., Taylor, R., Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267 (1997), 727–748.
28. [28] Nandy, S.K., Bhuyan, R., Seal, A., Modelling family 2 cystatins and their interaction with papain. J. Biomol. Struct. Dyn. 31 (2013), 649–664.
29. [29] Bhuyan, R., Nandy, S.K., Seal, A., An in silico structural insights into Plasmodium LytB protein and its inhibition. J. Biomol. Struct. Dyn. 33 (2015), 1198–1210.
30. [30] Dona, M., Dell'Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A., Garbisa, S., Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 170 (2003), 4335–4341.